ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 185

Accrual of Multimorbidity After Incident Rheumatoid Arthritis and Matched Comparators Using a Large Prospective Cohort with 30 Years of Follow-up

Kazuki Yoshida1, Tzu-Chieh Lin 2, Melissa Y Wei 3, Susan Malspeis 1, Su H. Chu 4, Carlos Camargo 5, Benjamin A. Raby 1, Hyon K. Choi 5, Sara K. Tedeschi 6, Medha Barbhaiya 7, Bing Lu 1, Karen Costenbader 1, Elizabeth Karlson 1 and Jeffrey Sparks 1, 1Brigham and Women's Hospital, Boston, MA, 2Amgen, Thousand Oaks, CA, 3University of Michigan, Ann Arbor, MI, 4Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 5Massachusetts General Hospital, Boston, MA, 6Brigham and Women's Hospital, Div. of Rheumatology, Immunology and Allergy, Boston, MA, 7Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Co-morbidities and epidemiologic methods, Rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Epidemiology & Public Health Poster I: RA

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) patients often suffer from multimorbidity, the coexistence of multiple chronic morbidities. However, little is known about how multimorbidity accrues over time among RA patients compared to similar individuals without RA. Thus, we aimed to describe the longitudinal trajectories of multimorbidity after incident RA and compared to age- and calendar year- matched non-RA comparators, both from a large prospective cohort of female nurses.

Methods: We conducted a prospective cohort study utilizing the Nurses’ Health Study, an ongoing (n = 121,700) prospective cohort of female registered nurses that began in 1976. Biennial questionnaires collected information on items such as sociodemographics, anthropometrics, dietary intake, and health conditions. Incident RA and date of diagnosis were determined by medical record review (all meeting 1987 ACR or 2010 ACR/EULAR classification criteria). For each woman with incident RA, we matched 10 non-RA comparators who had never reported RA at or prior to the index date (time of RA diagnosis) by age and calendar year. To quantify the potentially differential accumulation of multimorbidity over time, we used the validated Multimorbidity-Weighted Index (MWI), previously associated with physical function, mortality, and cognitive decline. We modified the MWI to exclude RA (exposure of interest), analyzing a total of 61 morbidities, each weighted according to their impact on the Short Form-36 physical functioning scale. The conditions included common and rare but debilitating conditions and spanned all organ systems; e.g., musculoskeletal (gout, osteoarthritis, osteoporosis, fractures, joint replacements), cardiovascular, and pulmonary systems. We demonstrated the trajectories of the overall MWI and components of the MWI over time in RA patients and their matched comparators. The between-group difference in trajectories was tested using linear mixed effect models.

Results: We identified 1,007 incident RA patients and matched 10,003 non-RA participants. Both had mean ages of 60 years (SD 10). Need to include mean follow-up time (big strength of the study). Past and current smoking was more common among RA individuals (65%) than comparators (56%). At baseline (Figure 1), the MWI was higher for the RA patients (mean 4.2) than matched comparators (mean 3.1). During the follow-up, MWI accrued more rapidly for RA patients than their matched comparators. For each decade, MWI score increased by 1.41 [95% confidence interval (CI) 1.20, 1.61] in RA patients. The largest contributor to the baseline difference and difference in trajectories over time was the musculoskeletal component of the MWI (Figure 2). Although similar at baseline, cardiovascular and pulmonary components of the MWI accrued more rapidly over time for the RA patients than the matched comparators.

Conclusion: Women with RA and their non-RA comparators exhibited differential accumulation of multimorbidity after incident RA. Since the MWI concomitantly captures current physical functioning and predicts future physical functioning, cognitive decline, and increased mortality, potential strategies to mitigate the accumulation of multimorbidity in RA patients are urgently needed.


mwi_progression_production

Accumulation of multimorbidity after the index date of RA diagnosis -n=1,007- or matched date for comparators -n=10,003- as quantified by the Multimorbidity Weighted Index.


mwi_progression_cat_production

Accumulation of the major components -musculoskeletal, cardiovascular, pulmonary, endocrine, gastrointestinal, and nervous- of the Multimorbidity Weighted Index after the index date of RA diagnosis -n=1,007- or matched date for comparators -n=10,003-


Disclosure: K. Yoshida, None; T. Lin, None; M. Wei, None; S. Malspeis, None; S. Chu, None; C. Camargo, None; B. Raby, None; H. Choi, AstraZeneca, 2, GSK, 5, Horizon, 5, Selecta, 5, Takeda, 5; S. Tedeschi, None; M. Barbhaiya, None; B. Lu, None; K. Costenbader, Astra-Zeneca, 2, Glaxo Smith Kline, 2, Janssen Scientific Affairs, LLC, 2, Lupus Foundation of America, 2, Lupus Research Alliance, 2, Merck, 2; E. Karlson, None; J. Sparks, None.

To cite this abstract in AMA style:

Yoshida K, Lin T, Wei M, Malspeis S, Chu S, Camargo C, Raby B, Choi H, Tedeschi S, Barbhaiya M, Lu B, Costenbader K, Karlson E, Sparks J. Accrual of Multimorbidity After Incident Rheumatoid Arthritis and Matched Comparators Using a Large Prospective Cohort with 30 Years of Follow-up [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/accrual-of-multimorbidity-after-incident-rheumatoid-arthritis-and-matched-comparators-using-a-large-prospective-cohort-with-30-years-of-follow-up/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/accrual-of-multimorbidity-after-incident-rheumatoid-arthritis-and-matched-comparators-using-a-large-prospective-cohort-with-30-years-of-follow-up/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology